Filing Details
- Accession Number:
- 0001161697-23-000243
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-07 17:00:21
- Reporting Period:
- 2023-04-05
- Accepted Time:
- 2023-04-07 17:00:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1369568 | Catalyst Pharmaceuticals Inc. | CPRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1292636 | S David Tierney | 355 Alhambra Circle, Suite 801 Coral Gables FL 33134 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2023-04-05 | 30,000 | $0.79 | 343,541 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2023-04-05 | 30,000 | $16.83 | 313,541 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to purchase common stock | Disposition | 2023-04-05 | 30,000 | $0.00 | 30,000 | $0.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 280,500 | 2023-06-15 | No | 4 | M | Direct |
Footnotes
- Dr. Tierney has advised the Company that the sale of shares was to pay the exercise price of the shares and to raise funds for personal reasons, and does not relate to any disagreements between Dr. Tierney and the Company on any matter relating to the Company's operations, policies or practices. Dr. Tierney remains a Director of the Company.
- Shares were sold in various lots from $16.70 to $16.98 per share. The listed sales price represents a weighted average price for the shares sold.
- The option was granted on June 15, 2016 and previously vested in two annual installments.
Billionaire Hedge Funds
